{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T10:00:26Z","timestamp":1774519226475,"version":"3.50.1"},"reference-count":43,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,8,10]],"date-time":"2022-08-10T00:00:00Z","timestamp":1660089600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Nutr."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>Obesity, often associated with non-alcoholic fatty liver disease (NAFLD), is characterized by an imbalance between energy expenditure and food intake, which is also reflected by desensitization of fibroblast growth factor 21 (FGF21). FGF21 is strongly influenced, among others, by TNF\u03b1, which is known to be upregulated in obesity-induced inflammation. Successful long-term treatments of NAFLD might be dietary modification, exercise, or fasting.<\/jats:p><\/jats:sec><jats:sec><jats:title>Materials and methods<\/jats:title><jats:p>Whether succeeded NAFLD recovery is linked with improved FGF21 sensitivity and finally reverted FGF21 resistance was the focus of the present study. For this purpose, mice received a high-fat diet (HFD) for 6 months to establish obesity. Afterward, the mice were subjected to three different weight loss interventions, namely, dietary change to low-fat diet (LFD), treadmill training, and\/or time-restricted feeding for additional 6 months, whereas one group remained on HFD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In addition to the expected decrease in NAFLD activity with dietary change, this was also observed in the HFD group with additional time-restricted feeding. There was also an associated decrease in hepatic TNF\u03b1 and FGF21 expression and an increase in \u00df-klotho expression, demonstrated mainly by using principal component analysis. Pearson correlation analysis shows that independent of any intervention, TNF\u03b1 expression decreased with improved NAFLD recovery. This was accompanied with higher FGF21 sensitivity, as expressed by an increase in \u03b2-klotho and FGFR1c expression and concomitantly decreased FGF21 levels.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>In summary, we conclude that successful NAFLD therapy is associated with a reversion of the TNF\u03b1-triggered FGF21-resistant state or desensitization.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fnut.2022.935805","type":"journal-article","created":{"date-parts":[[2022,8,10]],"date-time":"2022-08-10T06:57:01Z","timestamp":1660114621000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["The effect of different weight loss strategies to treat non-alcoholic fatty liver disease focusing on fibroblast growth factor 21"],"prefix":"10.3389","volume":"9","author":[{"given":"Nicole","family":"Power Guerra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katharina","family":"Leyens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luisa","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Brauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah","family":"Janowitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samin","family":"Schlick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristin","family":"Pilz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans J.","family":"Grabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brigitte","family":"Vollmar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Kuhla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,8,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1001\/archinte.149.7.1514","article-title":"The deadly quartet. Upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension.","volume":"149","author":"Kaplan","year":"1989","journal-title":"Arch Int Med."},{"key":"B2","first-page":"195","article-title":"Definition of metabolic syndrome: report of the national heart, lung, and blood institute\/american heart association conference on scientific issues related to definition.","volume":"25","author":"Beilby","year":"2004","journal-title":"Clin Biochem Rev."},{"key":"B3","doi-asserted-by":"crossref","first-page":"72","DOI":"10.4103\/0019-5359.19918","article-title":"Metabolic syndrome.","volume":"60","author":"Gogia","year":"2006","journal-title":"Indian J Med Sci."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.2337\/diabetes.50.8.1844","article-title":"Nonalcoholic fatty liver disease: a feature of the metabolic syndrome.","volume":"50","author":"Marchesini","year":"2001","journal-title":"Diabetes."},{"key":"B5","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1097\/MOL.0b013e32834c7cfc","article-title":"Nonalcoholic steatohepatitis: the therapeutic challenge of a global epidemic.","volume":"22","author":"Schattenberg","year":"2011","journal-title":"Curr Opin Lipidol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/nature05485","article-title":"Inflammation and metabolic disorders.","volume":"444","author":"Hotamisligil","year":"2006","journal-title":"Nature."},{"key":"B7","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1172\/JCI57132","article-title":"Inflammatory links between obesity and metabolic disease.","volume":"121","author":"Lumeng","year":"2011","journal-title":"J Clin Invest."},{"key":"B8","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/nature21363","article-title":"Inflammation, metaflammation and immunometabolic disorders.","volume":"542","author":"Hotamisligil","year":"2017","journal-title":"Nature."},{"key":"B9","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.beem.2005.07.009","article-title":"Adipose tissue: a regulator of inflammation.","volume":"19","author":"Juge-Aubry","year":"2005","journal-title":"Best Pract Res Clin Endocrinol Metab."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1172\/JCI20514","article-title":"Obesity-induced inflammatory changes in adipose tissue.","volume":"112","author":"Wellen","year":"2003","journal-title":"J Clin Invest."},{"key":"B11","doi-asserted-by":"publisher","first-page":"e47713","DOI":"10.1371\/journal.pone.0047713","article-title":"High fat diet-induced gut microbiota exacerbates inflammation and obesity in mice via the TLR4 signaling pathway.","volume":"7","author":"Kim","year":"2012","journal-title":"PLoS One."},{"key":"B12","doi-asserted-by":"publisher","first-page":"3375","DOI":"10.1111\/jcmm.14232","article-title":"Mesenteric adipose tissue B lymphocytes promote local and hepatic inflammation in non-alcoholic fatty liver disease mice.","volume":"23","author":"Wu","year":"2019","journal-title":"J Cell Mol Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1172\/JCI88881","article-title":"Liver inflammation and fibrosis.","volume":"127","author":"Koyama","year":"2017","journal-title":"J Clin Invest."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1172\/JCI92035","article-title":"Inflammatory mechanisms linking obesity and metabolic disease.","volume":"127","author":"Saltiel","year":"2017","journal-title":"J Clin Invest."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1172\/JCI23606","article-title":"FGF-21 as a novel metabolic regulator.","volume":"115","author":"Kharitonenkov","year":"2005","journal-title":"J Clin Invest."},{"key":"B16","doi-asserted-by":"publisher","first-page":"6018","DOI":"10.1210\/en.2008-0816","article-title":"Fibroblast growth factor 21 corrects obesity in mice.","volume":"149","author":"Coskun","year":"2008","journal-title":"Endocrinology."},{"key":"B17","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.tips.2018.12.002","article-title":"Emerging structure-function paradigm of endocrine FGFs in metabolic diseases.","volume":"40","author":"Luo","year":"2019","journal-title":"Trends Pharmacol Sci."},{"key":"B18","doi-asserted-by":"publisher","first-page":"901S","DOI":"10.3945\/ajcn.110.001941","article-title":"Fibroblast growth factor 21 is a metabolic regulator that plays a role in the adaptation to ketosis.","volume":"93","author":"Domouzoglou","year":"2011","journal-title":"Am J Clin Nutr."},{"key":"B19","doi-asserted-by":"publisher","first-page":"e00065","DOI":"10.7554\/eLife.00065","article-title":"The starvation hormone, fibroblast growth factor-21, extends lifespan in mice.","volume":"1","author":"Zhang","year":"2015","journal-title":"Elife."},{"key":"B20","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/ijo.2014.76","article-title":"Opposite alterations in FGF21 and FGF19 levels and disturbed expression of the receptor machinery for endocrine FGFs in obese patients.","volume":"39","author":"Gallego-Escuredo","year":"2015","journal-title":"Int J Obesity."},{"key":"B21","doi-asserted-by":"publisher","first-page":"2781","DOI":"10.2337\/db10-0193","article-title":"Obesity is a fibroblast growth factor 21 (FGF21)-resistant state.","volume":"59","author":"Fisher","year":"2010","journal-title":"Diabetes."},{"key":"B22","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/nrendo.2015.48","article-title":"Hypothalamic innate immune reaction in obesity.","volume":"11","author":"K\u00e4lin","year":"2015","journal-title":"Nat Rev Endocrinol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"289","DOI":"10.12688\/f1000research.14117.1","article-title":"Defining \u201cFGF21 Resistance\u201d during obesity: controversy, criteria and unresolved questions.","volume":"7","author":"Markan","year":"2018","journal-title":"F1000Res."},{"key":"B24","doi-asserted-by":"publisher","first-page":"4238","DOI":"10.1210\/en.2012-1193","article-title":"TNF-\u03b1 represses \u03b2-Klotho expression and impairs FGF21 action in adipose cells: involvement of JNK1 in the FGF21 pathway.","volume":"153","author":"D\u00edaz-Delf\u00edn","year":"2012","journal-title":"Endocrinology."},{"key":"B25","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1007\/s00125-017-4373-5","article-title":"Effects of insulin and exercise training on FGF21, its receptors and target genes in obesity and type 2 diabetes.","volume":"60","author":"Kruse","year":"2017","journal-title":"Diabetologia."},{"key":"B26","doi-asserted-by":"publisher","first-page":"2738","DOI":"10.1016\/j.celrep.2019.02.014","article-title":"Exercise alleviates obesity-induced metabolic dysfunction via enhancing FGF21 sensitivity in adipose tissues.","volume":"26","author":"Geng","year":"2019","journal-title":"Cell Rep."},{"key":"B27","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.cmet.2018.08.004","article-title":"Time-restricted feeding prevents obesity and metabolic syndrome in mice lacking a circadian clock.","volume":"29","author":"Chaix","year":"2019","journal-title":"Cell Metab."},{"key":"B28","doi-asserted-by":"publisher","first-page":"2916","DOI":"10.3390\/nu13092916","article-title":"Fibroblast growth factor 21 as a potential biomarker for improved locomotion and olfaction detection ability after weight reduction in obese mice.","volume":"13","author":"Power Guerra","year":"2021","journal-title":"Nutrients."},{"key":"B29","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/oby.2007.72","article-title":"Physical inactivity and obesity: a vicious circle.","volume":"16","author":"Pietil\u00e4inen","year":"2008","journal-title":"Obesity."},{"key":"B30","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1111\/j.1440-1681.2007.04635.x","article-title":"Maximal lactate steady state in running mice: effect of exercise training.","volume":"34","author":"Ferreira","year":"2007","journal-title":"Clin Exp Pharmacol Physiol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1002\/hep.21201","article-title":"Hepatocytes as cytotoxic effector cells can induce cell death by CD95 ligand-mediated pathway.","volume":"43","author":"Guy","year":"2006","journal-title":"Hepatology."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Nonalcoholic steatohepatitis clinical research network. Design and validation of a histological scoring system for nonalcoholic fatty liver disease.","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology."},{"key":"B33","doi-asserted-by":"publisher","first-page":"587","DOI":"10.3390\/biomedicines8120587","article-title":"Dietary-induced low-grade inflammation in the liver.","volume":"8","author":"Power Guerra","year":"2020","journal-title":"Biomedicines."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/1535370217738730","article-title":"Microcirculatory disturbances and cellular changes during progression of hepatic steatosis to liver tumors.","volume":"243","author":"Liebig","year":"2018","journal-title":"Exp Biol Med."},{"key":"B35","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.tjem.2018.08.001","article-title":"User\u2019s guide to correlation coefficients.","volume":"18","author":"Akoglu","year":"2018","journal-title":"Turk J Emerg Med."},{"key":"B36","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.jhep.2017.05.016","article-title":"Treatment of NAFLD with diet, physical activity and exercise.","volume":"67","author":"Romero-G\u00f3mez","year":"2017","journal-title":"J Hepatol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.3390\/ijms22052350","article-title":"Treatments for NAFLD: state of Art.","volume":"22","author":"Mantovani","year":"2021","journal-title":"Int J Mol Sci."},{"key":"B38","doi-asserted-by":"publisher","first-page":"9338","DOI":"10.3748\/wjg.v20.i28.9338","article-title":"Role of diet and lifestyle changes in nonalcoholic fatty liver disease.","volume":"20","author":"Nseir","year":"2014","journal-title":"World J Gastroenterol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"S193","DOI":"10.1002\/mnfr.201100040","article-title":"Regular endurance exercise improves the diminished hepatic carnitine status in mice fed a high-fat diet.","author":"Ringseis","year":"2011","journal-title":"Mol Nutr Food Res."},{"key":"B40","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/j.cmet.2014.11.001","article-title":"Time-restricted feeding is a preventative and therapeutic intervention against diverse nutritional challenges.","volume":"20","author":"Chaix","year":"2014","journal-title":"Cell Metab."},{"key":"B41","doi-asserted-by":"publisher","first-page":"e0196637","DOI":"10.1371\/journal.pone.0196637","article-title":"Effects of aerobic training with and without weight loss on insulin sensitivity and lipids.","volume":"13","author":"Swift","year":"2018","journal-title":"PLoS One."},{"key":"B42","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/j.cmet.2012.04.019","article-title":"Time-restricted feeding without reducing caloric intake prevents metabolic diseases in mice fed a high-fat diet.","volume":"15","author":"Hatori","year":"2012","journal-title":"Cell Metab."},{"key":"B43","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.jnutbio.2016.10.017","article-title":"Relationship between FGF21 and UCP1 levels under time-restricted feeding and high-fat diet.","volume":"40","author":"Chapnik","year":"2017","journal-title":"J Nutr Biochem."}],"container-title":["Frontiers in Nutrition"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2022.935805\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,10]],"date-time":"2022-08-10T06:57:07Z","timestamp":1660114627000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2022.935805\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,10]]},"references-count":43,"alternative-id":["10.3389\/fnut.2022.935805"],"URL":"https:\/\/doi.org\/10.3389\/fnut.2022.935805","relation":{},"ISSN":["2296-861X"],"issn-type":[{"value":"2296-861X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,10]]},"article-number":"935805"}}